International Journal of Respiratory Medicine

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Mini Review - International Journal of Respiratory Medicine (2023) Volume 8, Issue 5

Respiratory medications and diabetes: A comprehensive guide for patients

Hertanti Abelha*

Department of Medical Surgical Nursing, Universities of Gadjah Mada, Yogyakarta, Indonesia

*Corresponding Author:
Hertanti Abelha
Department of Medical Surgical Nursing
Universities of Gadjah Mada, Yogyakarta, Indonesia

Received: 30-Sep-2023, Manuscript No. AAIJRM-23-118943; Editor assigned: 02-Oct-2023, PreQC No. AAIJRM-23-118943(PQ); Reviewed: 16-Oct-2023, QC No. AAIJRM-23-118943; Revised: 16-Oct-2023, Manuscript No. AAIJRM-23-118943(R); Published: 23-Oct-2023, DOI: 10.35841/aaijrm-8.5.171

Citation: Abelha H. Respiratory medications and diabetes: Acomprehensive guide for patients. Int J Respir Med. 2023; 8(5):171

Visit for more related articles at International Journal of Respiratory Medicine


Diabetes and respiratory conditions often go hand in hand, and managing both can be challenging. Individuals with diabetes may also suffer from respiratory issues like asthma or chronic obstructive pulmonary disease (COPD). This article serves as a comprehensive guide for diabetic patients who need to use respiratory medications, particularly bronchodilators, to ensure their well-being while maintaining blood sugar control. It is not uncommon for individuals with diabetes to experience respiratory problems. Diabetes can affect various organs in the body, including the lungs. Chronic inflammation and high blood sugar levels can lead to a higher risk of respiratory issues, such as asthma and COPD. Moreover, some medications used to manage diabetes can also have side effects related to lung function. Recognizing the interplay between diabetes and respiratory conditions is essential for a holistic approach to healthcare [1, 2].

Bronchodilators are a class of medications primarily used to treat respiratory conditions, such as asthma and COPD. They work by relaxing the muscles surrounding the airways, making it easier to breathe. There are two main types of bronchodilators: beta-2 agonists and anticholinergic. It is crucial for individuals with diabetes to understand how these medications may affect their health and blood sugar control [3].

Beta-2 Agonists: Some beta-2 agonists, like albuterol, can cause a temporary increase in blood sugar levels. This is because they stimulate the release of glucose from the liver and reduce insulin sensitivity. While this effect is usually short-lived, diabetics need to monitor their blood sugar levels closely when using these medications. It is essential to communicate with your healthcare provider about your diabetes management plan to account for potential fluctuations. Anticholinergic bronchodilators, like tiotropium, typically have a milder impact on blood sugar levels compared to beta- 2 agonists. However, it's still crucial to monitor blood sugar levels regularly, as individual responses can vary. Discuss any concerns with your healthcare provider. Maintain open and regular communication with your healthcare provider. Discuss your diabetic management plan, including medications, and any adjustments needed when using bronchodilators. They can help you find the right balance [4].

Always follow your healthcare provider's instructions regarding medication usage. Ensure you are using bronchodilators correctly, as proper inhaler technique is crucial for their effectiveness and minimizing side effects. Regularly monitor your blood sugar levels, particularly before and after using bronchodilators. Keeping a log of your readings can help you and your healthcare provider make informed decisions. Adhering to a healthy diet and exercise routine can positively impact both your diabetes and respiratory health. It can help control blood sugar levels and enhance overall lung function. Avoid smoking, as it can exacerbate both diabetes and respiratory conditions. Reducing exposure to environmental triggers like allergens and pollutants can also help manage respiratory symptoms [5].


In conclusion, individuals with diabetes need not feel overwhelmed by the prospect of managing both diabetes and respiratory conditions. Understanding the effects of bronchodilators on blood sugar levels is crucial. With open communication, proper medication management, regular monitoring, a healthy lifestyle, and lifestyle modifications, it is possible to strike a balance that allows for the effective management of both conditions. The key to success lies in working closely with healthcare providers, who can tailor a comprehensive care plan to meet your unique needs. By following these strategies and staying informed, you can enjoy a better quality of life while managing diabetes and respiratory conditions effectively.


  1. Caballero AE, Ceriello A, Misra A, et al. COVID-19 in people living with diabetes: an international consensus. J Diabetes Complicat. 2020;34(9):107671.
  2. Indexed at, Google Scholar, Cross Ref

  3. Rangankar V, Koganti DV, Lamghare P, et al. Correlation between ct severity scoring and diabetes mellitus in patients with COVID-19 infection. Cureus. 2021;13(12).
  4. Indexed at, Google Scholar, Cross Ref

  5. Fathi N, Rezaei N. Lymphopenia in COVID-19: Therapeutic opportunities. Cell Biol Int. 2020;44(9):1792-7.
  6. Indexed at, Google Scholar, Cross Ref

  7. Chavez-Reyes J, Escarcega-Gonzalez CE, Chavira-Suarez E, et al. Susceptibility for some infectious diseases in patients with diabetes: the key role of glycemia. Front Public Health. 2021.
  8. Indexed at, Google Scholar, Cross Ref

  9. Shrivastava SR, Shrivastava PS, Ramasamy J. Role of self-care in management of diabetes mellitus. J Diabetes Metab Disord. 2013;12(1):1-5.
  10. Indexed at, Google Scholar, Cross Ref

Get the App